Starling et al., 1987 - Google Patents
Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen.Starling et al., 1987
View PDF- Document ID
- 7663751394515213636
- Author
- Starling G
- Davidson S
- McKenzie J
- Hart D
- Publication year
- Publication venue
- Immunology
External Links
Snippet
Three monoclonal antibodies recognizing different epitopes of the leucocyte common molecule, CMRF-11 (against the restricted or B-220 leucocyte common molecule), CMRF-12 and CMRF-26 [each against a different epitope on the non-restricted or T200 leucocyte …
- 230000002401 inhibitory effect 0 title abstract description 26
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Davis et al. | Decay-accelerating factor functions as a signal transducing molecule for human T cells. | |
Verhoeven et al. | Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils | |
Tanaka et al. | Fas ligand in human serum | |
Lecoanet-Henchoz et al. | CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18 | |
Sidorenko et al. | Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. | |
Azuma et al. | B70 antigen is a second ligand for CTLA-4 and CD28 | |
Sutherland et al. | UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells | |
Axelsson et al. | Induction of aggregation and enhancement of proliferation and IL-2 secretion in human T cells by antibodies to CD43. | |
AU679909B2 (en) | Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon | |
JP4099119B2 (en) | Surface complex lymphotoxin | |
JP5215723B2 (en) | Use of anti-CX3CR1 antibody, anti-fractalkine antibody and fractalkine | |
IE84069B1 (en) | Recombinant thrombin receptor and related pharmaceuticals | |
WO1992000092A1 (en) | Ligand for cd28 receptor on b cells and methods | |
US20070065875A1 (en) | NTB-A, a surface molecule involved in natural killer cells activity | |
LT4225B (en) | Immuno-stimulatory monoclonal antibodies | |
Shen et al. | The functional properties of Fcγ RI, II and III on myeloid cells: A comparative study of killing of erythrocytes and tumor cells mediated through the different Fc receptors | |
Starling et al. | Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen. | |
AU2002325333A1 (en) | NTB-A, a surface molecule involved in natural killer cells activity | |
Vĕtvicka et al. | Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3. | |
EP0625990B1 (en) | Glycoprotein complexes and glycoproteins | |
JP4263391B2 (en) | Use of anti-CX3CR1 antibody, anti-fractalkine antibody and fractalkine | |
Martin et al. | Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes. | |
Ortaldo et al. | Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF. | |
Hasegawa et al. | Monoclonal antibodies to epitope of CD45R (B220) inhibit interleukin 4-mediated B cell proliferation and differentiation | |
EP1367393A1 (en) | Methods for using the CD 163 pathway for modulating an immune response |